The Associate Director, GTN Balance Sheet & Systems, is responsible for the planning, reporting, governance, and integrity of the Gross-to-Net (GTN) balance sheet. This role provides financial leadership and oversight across GTN accounting processes, ensuring accurate, timely, and well-supported balance sheet results.
The Associate Director serves as the primary liaison among GTN Accounting, CCF, and the Systems Strategy Team. and reports to the Director, GTN Pricing US Therapeutics.
Responsibilities:
- Owns GTN balance sheet planning, forecasting, reporting, and analysis for Plan, LRP, and Latest Best Estimate (LBE), with primary responsibility for reserves, accruals, rebates, contra receivables, coupons, chargebacks, returns, discounts, and other applicable GTN-related balances.
- Establishes and maintain appropriate governance, controls, documentation, and review procedures for GTN balance sheet activities.
- Provides actionable quarter-over-quarter and year-over-year analysis of GTN balance sheet movements, including key drivers, forecast changes, aging, exposure, and potential financial impacts.
- Leads cash flow analysis for actual and forecast results.
- Servesas the primary GTN Accounting representative for systems strategy initiatives involving reserves, rebates, contra receivables, and coupons, including defining system requirements and leading user acceptance testing (UAT) for Kernel, CDL-F, Anaplan, and related platforms.
- Drives automation and continuous improvement initiatives to reduce manual processes, strengthen controls, and improve reporting efficiency.